 SAN DIEGO, March 24, 2021 PRNewswire -- Evofem Biosciences, Inc. NASDAQ: EVFM today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price to the public of 1.75 per share. The gross proceeds from the offering to Evofem, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately 30.0 million. 